Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Semaglutide delays 4-hour gastric emptying in women with PCOS and obesity
Authors:ID Jensterle Sever, Mojca (Author)
ID Ferjan, Simona (Author)
ID Ležaič, Luka (Author)
ID Sočan, Aljaž (Author)
ID Goričar, Katja (Author)
ID Zaletel, Katja (Author)
ID Janež, Andrej (Author)
Files:.pdf PDF - Presentation file, download (1,41 MB)
MD5: 452B2BAFD0DA6AC2A5A29979BD6B33D9
 
URL URL - Source URL, visit https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14944
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Context: Semaglutide could contribute to reduced energy intake and weight loss by delaying gastric emptying (GE). However, the evidence for notable effects of semaglutide is inconclusive and compromised by the use of indirect methodology. Objective: to evaluate the effect of once-weekly subcutaneous semaglutide 1.0 mg on late digestive period of GE after ingestion of a standardized solid test meal by using technetium scintigraphy, the reference method for this purpose. Design: We conducted single-blind, placebo-controlled trial with 20 obese women with PCOS (average age 35 (32.3-40.8) years), BMI 37 (30.7-39.8) kg/m2 ) randomized to s.c semaglutide 1.0 mg QW (S) or placebo (P) for 12 weeks. GE was assessed after ingestion of [99mT c] colloid in pancake labeled with radiopharmaceutical by scintigraphy using sequential static imaging and dynamic acquisition at baseline and at week 13. Estimation of GE was obtained by repeated imaging of remaining [99mT c] activity (RA) at fixed time intervals over 4 hours after ingestion. Results: From baseline to the study end, semaglutide increased the estimated retention of gastric contents by 3.5% at the 1st hour, 25.5% at 2nd , 38.0% at 3rd and 30.0% at the 4th hour after ingestion of the radioactively labeled solid meal. Four hours after ingestion, semaglutide retained 37% of solid meal in the stomach compared to no gastric retention in P group (p=0.002). Half time (T1/2 ) was significantly longer in S as compared to P (171 min vs 118 min, (p<0.001). Conclusion: Semaglutide markedly delayed 4-hour GE in women with PCOS and obesity. This article is protected by copyright. All rights reserved.
Keywords:PCOS, obesity, semaglutide
Publication status:Published
Publication version:Version of Record
Year of publishing:2023
Number of pages:str. 975-984
Numbering:Vol. 25, iss. 4
PID:20.500.12556/DiRROS-25127 New window
UDC:616.4
ISSN on article:1462-8902
DOI:10.1111/dom.14944 New window
COBISS.SI-ID:134184963 New window
Publication date in DiRROS:12.01.2026
Views:92
Downloads:53
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Diabetes, obesity and metabolism
Shortened title:Diabetes obes. metab.
Publisher:Blackwell Science
ISSN:1462-8902
COBISS.SI-ID:13290713 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0298-2019
Name:Geni, hormonske in osebnostne spremembe pri metabolnih motnjah

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0343-2022
Name:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:PCOS, debelost, semaglutid


Back